BR0007891A - Processo para a produção de proteìnas de efeito profilático ou terapêutico - Google Patents
Processo para a produção de proteìnas de efeito profilático ou terapêuticoInfo
- Publication number
- BR0007891A BR0007891A BR0007891-3A BR0007891A BR0007891A BR 0007891 A BR0007891 A BR 0007891A BR 0007891 A BR0007891 A BR 0007891A BR 0007891 A BR0007891 A BR 0007891A
- Authority
- BR
- Brazil
- Prior art keywords
- prophylactic
- proteins
- production
- therapeutic effect
- prophylactically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/15003—Source of blood for venous or arterial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150236—Pistons, i.e. cylindrical bodies that sit inside the syringe barrel, typically with an air tight seal, and slide in the barrel to create a vacuum or to expel blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150244—Rods for actuating or driving the piston, i.e. the cylindrical body that sits inside the syringe barrel, typically with an air tight seal, and slides in the barrel to create a vacuum or to expel blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150274—Manufacture or production processes or steps for blood sampling devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150755—Blood sample preparation for further analysis, e.g. by separating blood components or by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/153—Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Manufacturing & Machinery (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Clinical Laboratory Science (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
"PROCESSO PARA A PRODUçãO DE PROTEìNAS DE EFEITO PROFILáTICO OU TERAPêUTICO". A presente invenção se refere a um processo para a produção de uma proteína de efeito profilático ou terapêutico, sendo a seringa preenchida com um fluido corporal e incubada, formando-se em seguida no fluido corporal a proteína de efeito profilático ou terapêutico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19903876A DE19903876B4 (de) | 1999-02-01 | 1999-02-01 | Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten |
PCT/EP2000/000762 WO2000046249A1 (de) | 1999-02-01 | 2000-01-31 | Verfahren zur herstellung von il-1ra, einem therapeutisch wirksamen protein, aus körperflüssigkeiten |
Publications (2)
Publication Number | Publication Date |
---|---|
BR0007891A true BR0007891A (pt) | 2002-04-09 |
BRPI0007891B1 BRPI0007891B1 (pt) | 2016-11-29 |
Family
ID=7896001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0007891A BRPI0007891B1 (pt) | 1999-02-01 | 2000-01-31 | processo para a produção de il-1ra em uma seringa para uso como um medicamento |
Country Status (13)
Country | Link |
---|---|
US (2) | US6713246B1 (pt) |
EP (1) | EP1151004B1 (pt) |
JP (2) | JP4369623B2 (pt) |
KR (1) | KR100652534B1 (pt) |
AT (1) | ATE263782T1 (pt) |
AU (1) | AU758385B2 (pt) |
BR (1) | BRPI0007891B1 (pt) |
CA (1) | CA2364386C (pt) |
DE (2) | DE19903876B4 (pt) |
DK (1) | DK1151004T3 (pt) |
ES (1) | ES2219311T3 (pt) |
PT (1) | PT1151004E (pt) |
WO (1) | WO2000046249A1 (pt) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19903876B4 (de) * | 1999-02-01 | 2006-09-28 | Orthogen Gentechnologie Gmbh | Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten |
DE10213648B4 (de) | 2002-03-27 | 2011-12-15 | Semikron Elektronik Gmbh & Co. Kg | Leistungshalbleitermodul |
US7832566B2 (en) | 2002-05-24 | 2010-11-16 | Biomet Biologics, Llc | Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles |
US20060278588A1 (en) | 2002-05-24 | 2006-12-14 | Woodell-May Jennifer E | Apparatus and method for separating and concentrating fluids containing multiple components |
US8273347B2 (en) * | 2003-05-13 | 2012-09-25 | Depuy Spine, Inc. | Autologous treatment of degenerated disc with cells |
US7553827B2 (en) * | 2003-08-13 | 2009-06-30 | Depuy Spine, Inc. | Transdiscal administration of cycline compounds |
US7344716B2 (en) * | 2003-05-13 | 2008-03-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
US20040229878A1 (en) * | 2003-05-13 | 2004-11-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of P38 kinase |
US7429378B2 (en) * | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
CN101496917B (zh) * | 2003-05-21 | 2013-07-31 | 株式会社Jms | 细胞培养的血清调制装置和血清调制方法及细胞培养方法 |
US8361467B2 (en) * | 2003-07-30 | 2013-01-29 | Depuy Spine, Inc. | Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints |
US8895540B2 (en) | 2003-11-26 | 2014-11-25 | DePuy Synthes Products, LLC | Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
JP4225418B2 (ja) * | 2004-02-05 | 2009-02-18 | ソニー株式会社 | 複合装置 |
US20060057223A1 (en) * | 2004-09-10 | 2006-03-16 | Dimauro Thomas M | Intradiscal production of autologous interleukin antagonist |
US20060130853A1 (en) * | 2004-12-21 | 2006-06-22 | Dimauro Thomas M | Ultra violet therapies for spine-related pain |
SG158872A1 (en) | 2005-01-12 | 2010-02-26 | Biogen Idec Inc | METHOD FOR DELIVERING INTERFERON-β |
US20060177515A1 (en) * | 2005-02-09 | 2006-08-10 | Reinhold Schmieding | Method of producing autogenous or allogenic blood serum and related logistics |
US7288108B2 (en) * | 2005-03-14 | 2007-10-30 | Codman & Shurtleff, Inc. | Red light implant for treating Parkinson's disease |
KR100694994B1 (ko) | 2005-06-13 | 2007-03-14 | 씨제이 주식회사 | 사람 과립구 콜로니 형성인자 동종체 |
US7351253B2 (en) * | 2005-06-16 | 2008-04-01 | Codman & Shurtleff, Inc. | Intranasal red light probe for treating Alzheimer's disease |
US8167920B2 (en) * | 2005-10-31 | 2012-05-01 | Codman & Shurtleff, Inc. | Intranasal delivery of compounds that reduce intrancranial pressure |
GB0523638D0 (en) | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
DE102006005016A1 (de) * | 2006-02-03 | 2007-08-16 | Orthogen Ag | Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung |
US8034014B2 (en) | 2007-03-06 | 2011-10-11 | Biomet Biologics, Llc | Angiogenesis initation and growth |
US20080269762A1 (en) * | 2007-04-25 | 2008-10-30 | Biomet Manufacturing Corp. | Method and device for repair of cartilage defects |
US8986696B2 (en) * | 2007-12-21 | 2015-03-24 | Depuy Mitek, Inc. | Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
US20090162351A1 (en) * | 2007-12-21 | 2009-06-25 | Depuy Spine, Inc. | Transdiscal administration of inhibitors of p38 MAP kinase |
EP2620139B1 (en) | 2008-02-27 | 2016-07-20 | Biomet Biologics, LLC | Interleukin-1 receptor antagonist rich solutions |
US8753690B2 (en) * | 2008-02-27 | 2014-06-17 | Biomet Biologics, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
US9320914B2 (en) | 2008-03-03 | 2016-04-26 | DePuy Synthes Products, Inc. | Endoscopic delivery of red/NIR light to the subventricular zone |
US8460227B2 (en) * | 2008-11-17 | 2013-06-11 | Arthrex, Inc. | Cytokine concentration system |
US20100198316A1 (en) * | 2009-02-04 | 2010-08-05 | Richard Toselli | Intracranial Red Light Treatment Device For Chronic Pain |
EP2416789B1 (en) | 2009-04-07 | 2017-06-21 | Velin-Pharma A/S | Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system |
CA2772084C (en) * | 2009-08-27 | 2016-10-18 | Biomet Biologics, Llc | Implantable device for production of interleukin-1 receptor antagonist |
US20110052561A1 (en) * | 2009-08-27 | 2011-03-03 | Biomet Biologics,LLC | Osteolysis treatment |
DK2475372T4 (da) | 2009-09-10 | 2020-11-30 | Velin Pharma As | Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse |
DE202009017772U1 (de) | 2009-12-10 | 2011-04-21 | Orthogen Ag | Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid |
AU2011296356B2 (en) | 2010-09-03 | 2015-07-09 | Biomet Biologics, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
DE102010042356A1 (de) | 2010-10-12 | 2012-04-12 | Henke-Sass, Wolf Gmbh | Behälter für die Herstellung einer konditionierten Blutzusammensetzung |
WO2012076194A1 (de) | 2010-12-10 | 2012-06-14 | Orthogen Ag | Kombinationspräparate mit cytokin-antagonist und corticosteroid |
WO2012076193A1 (de) | 2010-12-10 | 2012-06-14 | Orthogen Ag | Kombinationspräparate mit exosomen und corticosteroid |
US9011846B2 (en) | 2011-05-02 | 2015-04-21 | Biomet Biologics, Llc | Thrombin isolated from blood and blood fractions |
WO2013114359A1 (en) * | 2012-01-31 | 2013-08-08 | Estar Technologies Ltd | System and method for producing interleukin receptor antagonist (ira) |
US9205110B2 (en) | 2012-07-18 | 2015-12-08 | Arthrex, Inc. | Enhanced autologous growth factor production and delivery system |
US9241977B2 (en) | 2013-03-01 | 2016-01-26 | Arthrex, Inc. | Enhanced anabolic cytokine production and delivery system |
US20140271589A1 (en) | 2013-03-15 | 2014-09-18 | Biomet Biologics, Llc | Treatment of collagen defects using protein solutions |
US10208095B2 (en) | 2013-03-15 | 2019-02-19 | Biomet Manufacturing, Llc | Methods for making cytokine compositions from tissues using non-centrifugal methods |
US9758806B2 (en) | 2013-03-15 | 2017-09-12 | Biomet Biologics, Llc | Acellular compositions for treating inflammatory disorders |
US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
US9878011B2 (en) | 2013-03-15 | 2018-01-30 | Biomet Biologics, Llc | Treatment of inflammatory respiratory disease using biological solutions |
US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
EP2829278A1 (de) | 2013-07-23 | 2015-01-28 | Scientific BioTech GmbH | Serum zur Behnandlung von Krankheiten |
EP3074507B1 (en) | 2013-11-26 | 2022-01-05 | Biomet Biologics, LLC | Methods of mediating macrophage phenotypes |
WO2015085348A1 (en) * | 2013-12-09 | 2015-06-18 | Cytokine Medical Australia Pty Ltd | Apparatus for producing therapeutically active proteins in blood and uses thereof |
EP3161479B1 (en) * | 2014-06-30 | 2019-09-04 | Biomet Biologics, LLC | Methods for assessing the efficacy of anti-inflammatory cytokine compositions |
CA2866480A1 (en) | 2014-09-30 | 2016-03-30 | Antnor Limited | Method and composition for producing enhanced anti-inflammatory and regenerative agents from autologous physiological fluid |
US10441635B2 (en) | 2014-11-10 | 2019-10-15 | Biomet Biologics, Llc | Methods of treating pain using protein solutions |
US9763800B2 (en) | 2015-03-18 | 2017-09-19 | Biomet C. V. | Implant configured for hammertoe and small bone fixation |
EP3175920A1 (en) | 2015-12-03 | 2017-06-07 | Vetlinebio AB | Method and devices for producing serum |
US10960026B2 (en) | 2016-03-10 | 2021-03-30 | Arthrex, Inc. | Systems and methods for preparing protein enhanced serums |
AU2017230806B2 (en) | 2016-03-10 | 2021-06-24 | Arthrex, Inc. | Systems and methods for preparing a thrombin serum |
EP3470142A1 (de) | 2017-10-11 | 2019-04-17 | Orthogen AG | Vorrichtung mit einer ersten kammer zur aufnahme eines körperfluids |
EP3613424A1 (en) | 2018-08-23 | 2020-02-26 | Orthogen AG | Novel methods for the production of pharmaceutical agents |
CA3076046A1 (en) * | 2020-03-17 | 2021-09-17 | Antnor Limited | Method for producing enhanced anti-inflammatory/anti-catabolic agents from autologous physiological fluid with shortened incubation time |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3360290D1 (en) * | 1982-03-13 | 1985-07-25 | Boehringer Mannheim Gmbh | Device for the detection of bacteria, fungi and viruses in blood |
US5075222A (en) * | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
JP2834514B2 (ja) * | 1990-02-14 | 1998-12-09 | 株式会社バイオマテリアル研究所 | 血液細胞処理剤 |
US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
DE4244437A1 (de) * | 1992-12-29 | 1994-07-28 | Horst Dr Med Kief | Verfahren zur Gewinnung körpereigener Zytokine |
JP3400852B2 (ja) * | 1993-06-24 | 2003-04-28 | 株式会社ニックス | タンパク質回収装置 |
US5508262A (en) * | 1993-12-15 | 1996-04-16 | University Of South Florida | Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
FI1592U1 (fi) * | 1994-07-11 | 1994-10-26 | Elias Hakalehto | Spruta, foeretraedesvis injektionsspruta |
KR0129833B1 (ko) | 1994-11-09 | 1998-04-04 | 박성수 | 조직 배양 방법 및 장치 |
US6096728A (en) * | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US5972880A (en) | 1996-03-07 | 1999-10-26 | Arthro Lab Inc. | Method of treatment of osteoarthritis with interleuken-1 receptor antagonist |
CA2253549C (en) * | 1996-06-18 | 2005-10-25 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
US6294170B1 (en) * | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
WO1998051785A1 (en) * | 1997-05-14 | 1998-11-19 | The General Hospital Corporation | Co-cultivation of cells in a micropatterned configuration |
CH694074A5 (de) * | 1997-08-16 | 2004-07-15 | Orthogen Gentechnologie Gmbh | Verfahren zur Herstellung von therapeutisch wirksamen Proteinen. |
DE19903876B4 (de) * | 1999-02-01 | 2006-09-28 | Orthogen Gentechnologie Gmbh | Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten |
-
1999
- 1999-02-01 DE DE19903876A patent/DE19903876B4/de not_active Expired - Fee Related
-
2000
- 2000-01-31 WO PCT/EP2000/000762 patent/WO2000046249A1/de active IP Right Grant
- 2000-01-31 JP JP2000597319A patent/JP4369623B2/ja not_active Expired - Fee Related
- 2000-01-31 KR KR1020017009631A patent/KR100652534B1/ko active IP Right Grant
- 2000-01-31 PT PT00906255T patent/PT1151004E/pt unknown
- 2000-01-31 ES ES00906255T patent/ES2219311T3/es not_active Expired - Lifetime
- 2000-01-31 DK DK00906255T patent/DK1151004T3/da active
- 2000-01-31 EP EP00906255A patent/EP1151004B1/de not_active Expired - Lifetime
- 2000-01-31 DE DE50005985.3A patent/DE50005985C9/de not_active Expired - Lifetime
- 2000-01-31 AT AT00906255T patent/ATE263782T1/de active
- 2000-01-31 US US09/890,723 patent/US6713246B1/en not_active Expired - Lifetime
- 2000-01-31 BR BRPI0007891A patent/BRPI0007891B1/pt not_active IP Right Cessation
- 2000-01-31 CA CA2364386A patent/CA2364386C/en not_active Expired - Fee Related
- 2000-01-31 AU AU28002/00A patent/AU758385B2/en not_active Expired
-
2002
- 2002-12-31 US US10/331,583 patent/US6759188B2/en not_active Expired - Lifetime
-
2007
- 2007-03-15 JP JP2007067548A patent/JP2007244875A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE50005985C5 (de) | 2014-04-17 |
AU758385B2 (en) | 2003-03-20 |
EP1151004B1 (de) | 2004-04-07 |
DK1151004T3 (da) | 2004-08-09 |
PT1151004E (pt) | 2004-08-31 |
DE50005985D1 (de) | 2004-05-13 |
BRPI0007891B1 (pt) | 2016-11-29 |
US6713246B1 (en) | 2004-03-30 |
KR100652534B1 (ko) | 2006-12-01 |
CA2364386A1 (en) | 2000-08-10 |
AU2800200A (en) | 2000-08-25 |
DE19903876B4 (de) | 2006-09-28 |
EP1151004A1 (de) | 2001-11-07 |
DE50005985C9 (de) | 2014-07-10 |
JP2007244875A (ja) | 2007-09-27 |
DE19903876A1 (de) | 2000-08-10 |
US6759188B2 (en) | 2004-07-06 |
JP2002540818A (ja) | 2002-12-03 |
WO2000046249A1 (de) | 2000-08-10 |
ATE263782T1 (de) | 2004-04-15 |
KR20020007297A (ko) | 2002-01-26 |
ES2219311T3 (es) | 2004-12-01 |
JP4369623B2 (ja) | 2009-11-25 |
CA2364386C (en) | 2011-12-06 |
US20030138910A1 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0007891A (pt) | Processo para a produção de proteìnas de efeito profilático ou terapêutico | |
MXPA05013564A (es) | Proteinas de fusion. | |
HUP0303246A2 (hu) | Aktív fehérjék fokozott kinyerése | |
CA2301174A1 (en) | A method for inducing therapeutically-effective proteins | |
BG108443A (en) | Substituted oxazoliidinones for combinational therapy | |
ATE234108T1 (de) | Therapeutikum zur unterdrückung von schnarchgeräuschen | |
TR200002731T2 (tr) | Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar | |
AU2002352431A1 (en) | System, method, and article of manufacture for profiling an application targeted for reconfigurable logic using calls to profiling functions | |
GB0100513D0 (en) | Process | |
WO2003030927A3 (fr) | Utilisation de peptides analogues de la thymuline (pat) pour la fabrication de medicaments contre la douleur | |
BR9807936A (pt) | Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação | |
UY27841A1 (es) | Amidas de ácidos 2-heteroarilcarboxílicos | |
AU2000276877A1 (en) | Process for producing gel sheet for application to living body, gel sheet for application to living body obtained by the production process, and method of skin care with the same | |
AU2002215868A1 (en) | Protein shaped body and method for the production thereof according to the nmmo method | |
ES2191449T3 (es) | Derivados de ciclopentabenzofurano y su uso. | |
HUP0102562A2 (hu) | Expressziós vektor egyetlen lépésből álló tisztítási eljárásban történő alkalmazásra | |
WO2003022883A3 (de) | Verwendung eines proteins zur herstellung eines medikaments zur stimulierung des angeborenen unspezifischen immunsystems | |
ID22561A (id) | Konjugasi protein landak aktif, proses produksi dan penggunaannya | |
HU9300349D0 (en) | Method for producing dibenzo- or benzo-pyrido-cyclohepta-piperidine derivatives or piperidylidene or piperazine derivatives thereof as well as pharmaceutical preparatives contqining them | |
MY119688A (en) | Use of arylguanidinium xanthogenates as vulcanization accelerators and process for the production thereof | |
WO2001075021A3 (fr) | Nouveau polypeptide, proteine humaine associee au transport de glucose 10, et polynucleotide codant pour ce polypeptide | |
ATE443695T1 (de) | Doppelester | |
WO2001083677A3 (fr) | Nouveau polypeptide, proteine humaine fh2-13 de deformation des ailes de coq, et polynucleotide codant pour ce polypeptide | |
WO2001075015A3 (fr) | Nouveau polypeptide, fat24, et polynucleotide codant pour ce polypeptide | |
AU3553700A (en) | Preparation for the treatment of pigmentation disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/11/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2616 DE 23-02-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |